Singh, A. K., Kushwaha, P. P., Prajapati, K. S., Shuaib, M., Gupta, S., & Kumar, S. (2021). Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study. Comput Biol Med.

Singh, Atul Kumar, Prem Prakash Kushwaha, Kumari Sunita Prajapati, Mohd Shuaib, Sanjay Gupta, und Shashank Kumar. "Identification of FDA Approved Drugs and Nucleoside Analogues As Potential SARS-CoV-2 A1pp Domain Inhibitor: An in Silico Study." Comput Biol Med 2021.

Singh, Atul Kumar, et al. "Identification of FDA Approved Drugs and Nucleoside Analogues As Potential SARS-CoV-2 A1pp Domain Inhibitor: An in Silico Study." Comput Biol Med 2021.